| 000 | 01824 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250518083727.0 | ||
| 264 | 0 | _c20210111 | |
| 008 | 202101s 0 0 eng d | ||
| 022 | _a1880-4233 | ||
| 024 | 7 |
_a10.1007/s12282-020-01055-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMaroufi, Nazila Fathi | |
| 245 | 0 | 0 |
_aThe apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways. _h[electronic resource] |
| 260 |
_bBreast cancer (Tokyo, Japan) _cJul 2020 |
||
| 300 |
_a613-620 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCell Cycle Checkpoints _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Movement _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 |
_aNeoplasm Invasiveness _xprevention & control |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 |
_aSpheroids, Cellular _xdrug effects |
| 700 | 1 | _aVahedian, Vahid | |
| 700 | 1 | _aAkbarzadeh, Maryam | |
| 700 | 1 | _aMohammadian, Mahshid | |
| 700 | 1 | _aZahedi, Mohammadsaeid | |
| 700 | 1 | _aIsazadeh, Alireza | |
| 700 | 1 | _aPouremamali, Farhad | |
| 700 | 1 | _aTaefehshokr, Sina | |
| 700 | 1 | _aHeidari, Masoud | |
| 700 | 1 | _aRashidi, Mohammadreza | |
| 700 | 1 | _aNouri, Mohammad | |
| 773 | 0 |
_tBreast cancer (Tokyo, Japan) _gvol. 27 _gno. 4 _gp. 613-620 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12282-020-01055-6 _zAvailable from publisher's website |
| 999 |
_c30603288 _d30603288 |
||